407317001: Adalimumab (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Immunomodulator\Tumor necrosis factor alpha inhibitor\Adalimumab (substance)

\Drug or medicament (substance)\Tumor necrosis factor alpha inhibitor\Adalimumab (substance)
\Drug or medicament (substance)\Immunologic agent (substance)\Adalimumab (substance)
\Drug or medicament (substance)\Monoclonal antibody\Adalimumab (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Adalimumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Adalimumab (substance)

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Adalimumab (substance)
\Biological substance\Polypeptide (substance)\Protein\Antibody\Monoclonal antibody\Adalimumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2151148012 Adalimumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2158924011 Adalimumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

789171000172111 adalimumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

789181000172114 adalimumab nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Belgian module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Adalimumab (substance)	Is a	Monoclonal antibody agent	false	Inferred relationship	Some
Adalimumab (substance)	Is a	Anti-rheumatic agent	false	Inferred relationship	Some
Adalimumab (substance)	Is a	Tumor necrosis factor alpha inhibitor	true	Inferred relationship	Some
Adalimumab (substance)	Is a	Monoclonal antibody	true	Inferred relationship	Some
Adalimumab (substance)	Has disposition (attribute)	Tumor necrosis factor alpha inhibitor (disposition)	true	Inferred relationship	Some
Adalimumab (substance)	Is a	Immunologic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Adalimumab 40mg injection solution 0.8mL prefilled syringe	Has active ingredient	False	Adalimumab (substance)	Inferred relationship	Some
Product containing adalimumab (medicinal product)	Has active ingredient	True	Adalimumab (substance)	Inferred relationship	Some	1
Adalimunab 40mg/mL injection solution 1mL prefilled syringe	Has active ingredient	False	Adalimumab (substance)	Inferred relationship	Some
Adalimumab therapy (procedure)	Direct substance	True	Adalimumab (substance)	Inferred relationship	Some	2
Product containing precisely adalimumab 40 milligram/0.8 milliliter conventional release solution for injection syringe	Has precise active ingredient	False	Adalimumab (substance)	Inferred relationship	Some	1
Product containing precisely adalimumab 40 milligram/0.8 milliliter conventional release solution for injection syringe	Has basis of strength substance (attribute)	False	Adalimumab (substance)	Inferred relationship	Some	1
Product containing adalimumab in parenteral dose form (medicinal product form)	Has active ingredient	True	Adalimumab (substance)	Inferred relationship	Some	1
Product containing only adalimumab (medicinal product)	Has active ingredient	True	Adalimumab (substance)	Inferred relationship	Some	1
Adalimumab only product in parenteral dose form	Has active ingredient	True	Adalimumab (substance)	Inferred relationship	Some	1
Adalimumab 50 mg/mL solution for injection	Has basis of strength substance (attribute)	True	Adalimumab (substance)	Inferred relationship	Some	1
Adalimumab 50 mg/mL solution for injection	Has precise active ingredient	True	Adalimumab (substance)	Inferred relationship	Some	1
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Adalimumab (substance)	Inferred relationship	Some	1
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Adalimumab (substance)	Inferred relationship	Some	1

Reference Sets

Belgian subset for AllergyIntolerance, causative agent, drug